For patients where cardiovascular protection is a priority, semaglutide is the preferred GLP-1 medication
Liraglutide was found to directly affect the formation of atherosclerotic lesions by tilting the macrophage population to the M--2 phenotype that is conducive to decomposition (127)
These findings could suggest that the effect of liraglutide on hyperandrogenism does not depend exclusively on weight loss, it can also occur at low doses, and that there is probably a synergistic action with metformin
One such drug is Amgens Maridebart cafraglutide (MariTide, formerly AMG 133)
For semaglutide, our semaglutide conversion chart translates between milligrams and units
sleeve gastrectomy: A three-arm non-randomised, controlled, pilot study